Trial updateOphthalmology
Safety Study of Tivanisiran to Treat Dry Eye
Completed. Phase 3. Registered enrolment: 301. Sylentis, S.A.
Why it matters
Track this study through NCT05310422. Results are available in the registry.
The study at a glance
- Registry status
- Completed
- Phase
- Phase 3
- Registered enrolment
- 301
- Results posted
- Yes
- Sponsor
- Sylentis, S.A.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.